Muscular dystrophy, which affects approximately 250,000 people in the U.S., occurs when damaged muscle tissue is replaced with fibrous, fatty or bony tissue and loses function. For years, scientists have searched for a way to successfully treat the most common form of the disease, Duchenne Muscular Dystrophy (DMD), which primarily affects boys. Now, a team of University of Missouri researchers have successfully treated dogs with DMD and say that human clinical trials are being planned in the next few years.
“This is the most common muscle disease in boys, and there is currently no effective therapy,” saidDongsheng Duan, the study leader and the Margaret Proctor Mulligan Professor in Medical Research at the MU School of Medicine. “This discovery took our research team more than 10 years, but we believe we are on the cusp of having a treatment for the disease.”
Patients with Duchenne muscular dystrophy have a gene mutation that disrupts the production of a protein known as “dystrophin.” Absence of dystrophin starts a chain reaction that eventually leads to muscle cell degeneration and death. Affected boys lose their ability to walk and breathe as they get older. This places significant limitations on individuals afflicted with the disease. Dystrophin also is one of the largest genes in the human body.
“Due to its size, it is impossible to deliver the entire gene with a gene therapy vector, which is the vehicle that carries the therapeutic gene to the correct site in the body,” Duan said. “Through previous research, we were able to develop a miniature version of this gene called a microgene. This minimized dystrophin protected all muscles in the body of diseased mice.”
However, it took the team more than 10 years to develop a strategy that can safely send the micro-dystrophin to every muscle in a dog that is afflicted by the disease. The dog has a body size similar to that of an affected boy. Success in the dog will set the foundation for human tests.
In this latest study, the MU team demonstrated for the first time that a common virus can deliver the microgene to all muscles in the body of a diseased dog. The dogs were injected with the virus when they were two to three months old and just starting to show signs of DMD. The dogs are now six to seven months old and continue to develop normally.
“The virus we are using is one of the most common viruses; it is also a virus that produces no symptoms in the human body, making this a safe way to spread the dystrophin gene throughout the body,” Duan said. “These dogs develop DMD naturally in a similar manner as humans. It’s important to treat DMD early before the disease does a lot of damage as this therapy has the greatest impact at the early stages in life.”
The Latest on: Muscular Dystrophy
via Google News
The Latest on: Muscular Dystrophy
- Santhera Reports 2019 Annual Results and Highlights Pipeline Progress in Duchenne Muscular Dystrophyon March 23, 2020 at 11:00 pm
A conference call will be held today at 13:00 CET, 12:00 GMT, 08:00 EDT. Details are at the end of this statement. Net revenues ...
- Invitae and Muscular Dystrophy Association (MDA) Expand Access to No-Charge Genetic Testing in the U.S. and Canadaon March 23, 2020 at 5:31 pm
to offer sponsored, no-charge genetic testing to patients through the Detect Muscular Dystrophy program in MDA's care center network, a network of clinics at more than 150 of the nation's top ...
- Scene Calendar: Fun things to do March 20-26, 2020on March 21, 2020 at 6:10 am
Editor’s note: Please check with the venue before attending an event. There are a number of cancellations and postponed performances due to the outbreak of COVID-19, and venues may change these events ...
- Bay Area business community set to raise millions for nonprofits, essential equipmenton March 20, 2020 at 5:35 am
In an hour-long phone briefing with CEOs, the Silicon Valley Leadership Group raised $600,000 of a nearly $7 million goal to pay for medical supplies related to COVID-19. #coronavirus ...
- Capricor Therapeutics' (CAPR) CEO Linda Marban on Q4 2019 Results - Earnings Call Transcripton March 18, 2020 at 5:21 pm
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2019 Earnings Conference Call March 18, 2020, 04:30 PM ET Company Participants AJ Bergmann - CFO Linda Marban - Pre ...
- What Living With Duchenne Muscular Dystrophy Has Taught Meon March 16, 2020 at 12:10 am
For the past 23 years, I have battled a rare neuromuscular disease named Duchenne muscular dystrophy (DMD). It causes my muscles to waste away over time, so I use a power wheelchair and have little ...
- Jacksonville firefighters 'Fill the Boot' to help children with muscular dystrophyon March 12, 2020 at 1:09 pm
The Jacksonville Association of Firefighters' annual Fill the Boot campaign will raise funds to help transform the lives of children with muscular dystrophy. Anna Hopson has the strength and courage ...
- Winnipeg firefighters camping to raise awareness for Muscular Dystrophyon March 12, 2020 at 10:16 am
Global News Morning hangs out with Winnipeg Firefighters as they camp out in support of Muscular Dystrophy and explain why the cause is important to them.
- Raising awareness for Muscular Dystrophyon March 12, 2020 at 10:04 am
Winnipeg Firefighters are camping out at Station 4 in Osborne Village to raise funds Muscular Dystrophy.
- Muscular Dystrophy Association Launches MDA Let's Play, A Community Fundraising Platform for Gamingon March 12, 2020 at 6:05 am
NEW YORK, March 12, 2020 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) is launching MDA Let's Play and will have its first Game-a-thon event with famous Twitch influencer, Wade, known as ...
via Bing News